2006
DOI: 10.1016/j.jpedsurg.2005.10.018
|View full text |Cite
|
Sign up to set email alerts
|

Heparin-binding epidermal growth factor–like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
81
0
3

Year Published

2007
2007
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(88 citation statements)
references
References 19 publications
4
81
0
3
Order By: Relevance
“…[15][16][17] HB-EGF is found in biologically significant quantities in breast milk and [15][16][17] found that treatment with HB-EGF resulted in reduced apoptosis, increased proliferation and migration, as well as maintenance of the epithelial barrier and mucosal integrity compared with control animals. The reduction of HB-EGF in pasteurized milk may have negative implications on the intestinal integrity of preterm infants, compared with MOM.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[15][16][17] HB-EGF is found in biologically significant quantities in breast milk and [15][16][17] found that treatment with HB-EGF resulted in reduced apoptosis, increased proliferation and migration, as well as maintenance of the epithelial barrier and mucosal integrity compared with control animals. The reduction of HB-EGF in pasteurized milk may have negative implications on the intestinal integrity of preterm infants, compared with MOM.…”
Section: Discussionmentioning
confidence: 99%
“…In a series of experiments using a neonatal rat model of NEC, Feng et al [15][16][17] determined that treatment with HB-EGF resulted in reduced apoptosis, increased proliferation and migration, as well as maintenance of the epithelial barrier and mucosal integrity compared with control animals.…”
Section: Introductionmentioning
confidence: 99%
“…Heparin-binding epidermal growth factor (HB-EGF) has similar effects (26) and has been shown to reduce inflammation in a rat model (27). Trials to test EGF and HB-EGF in premature infants at risk of NEC are planned, if problems can be overcome in regards to obtaining EGF and HB-EGF suitable for administration to preterm infants.…”
Section: Session Iii: Prevention and Treatmentmentioning
confidence: 99%
“…(HB-EGF), [20][21][22] EGF, 23 other enteral growth factors 24,25 or probiotics 26,27 could be administered to term neonates that require NICU admission, using a randomized, placebo-controlled and masked design. Alternatively, if human milk was postulated to be protective, studies that randomized bottle-fed infants to banked human milk vs formula could be tested.…”
Section: Nec In Term Infantsmentioning
confidence: 99%